missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CACNG8 (aa 42-87) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (91%), Rat (91%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-59528 (PA5-59528. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Regulates the trafficking and gating properties of AMPA- selective glutamate receptors (AMPARs). Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization. Does not show subunit-specific AMPA receptor regulation and regulates all AMPAR subunits. Thought to stabilize the calcium channel in an inactivated (closed) state.
Specifications
Specifications
| Accession Number | Q8WXS5 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 59283 |
| Name | Human CACNG8 (aa 42-87) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | CACNG6; Cacng8; calcium channel, voltage-dependent, gamma subunit 8; calcium voltage-gated channel auxiliary subunit gamma 8; CaVGamma8; mir-935; Neuronal voltage-gated calcium channel gamma-8 subunit; TARP gamma 8; TARP gamma-8; Transmembrane AMPAR regulatory protein gamma-8; voltage-dependent calcium channel gamma-8 subunit |
| Common Name | CACNG8 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction